TrialViruses2021
Oral Selective TLR8 Agonist Selgantolimod Induces Multiple Immune Cell Responses in Humans.
Natarajan Ayithan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
TrialViruses2021
Natarajan Ayithan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.